Journal of Generic Medicines
The Business Journal for the Generic Medicines SectorJournal of Generic Medicines is the major, peer-reviewed, international business journal written by and for professionals working in the generic medicines sector. It includes expert analysis, briefings and legal updates on all aspects of business development, regulatory affairs, manufacturing and marketing affecting the generic pharmaceutical industry. Each quarterly issue publishes papers which are of direct relevance to practitioners and that meet the highest intellectual standards.
This journal is a member of the Committee on Publication Ethics (COPE).
Submit your manuscript today at https://mc.manuscriptcentral.com/jgm
Under the guidance of a highly respected Editor and an expert Editorial Board each quarterly issue publishes peer-reviewed analyses, briefings and updates which are of direct relevance to practitioners and that meet the highest intellectual standards.
Subscribing to Journal of Generic Medicines will give you and your organization access to the latest thinking from some of the world's leading authorities, including articles on:
- strategies for challenging and protecting patents
- pricing and reimbursement trends and policies - country by country
- fair and unfair tactics to block generic competition
- patent expiries and their impact on national, regional and global markets
- business development strategies and licensing agreements
- clinical trials and bioequivalence studies
- m&a strategy
- regulatory affairs
- major buyers' tender procedures
- data exclusivity and patents
- manufacturing and outsourcing
- briefings from government agencies
- marketing and branding strategies
- strategies for challenging innovators
- analysis of disease sectors
- own brand markets
- R&D
- legal briefings - including case law discussions
- market reviews
- the OTC generic market
- packaging and labelling
- biogenerics
- purchase strategies
| Brian Tempest | Hale & Tempest Co Ltd., UK |
| Ranjit Barshikar | Quality by Design / cGMP, India |
| Paul Braier | Greenblum & Bernstein PLC, USA |
| Nicholas Cappuccino | Pharmaceutical Intellectual Resource Services LLC, USA |
| Carlos M. Correa | University of Buenos Aires, Argentina |
| Dolores Cullen | MFJ International, USA |
| Sanjeev Dani | Aurobindo Pharma, India |
| Marcel Daniels | Teva Pharmaceutical Industries Ltd, Belgium |
| Debashis Dasgupta | Kent Pharmaceuticals, UK |
| Richard L. DiCicco | Technology Catalysts International, USA |
| Eric B. Fastiff | Lieff Cabraser Heimann & Bernstein, USA |
| Thomas Faunce | Australian National University, Australia |
| Rahul Garella | Strides, Europe |
| Biju Jacob | Strides, UAE |
| Sudarshan Jain | IPA Secretary General, India and Asia (excluding Japan) |
| Gordon Johnston | Generic Pharmaceutical Association, USA |
| Fabiana Jorge | MFJ International, USA |
| Sandeep Juneja | TB Alliance, USA |
| Yahudah Livneh | VP Corporate IP & Legislative Affairs, Israel |
| Yehudah Livneh | Livneh Associates, Israel |
| Kate Lynch | Generic Medicines Industry Association Pty Ltd, Austrialia |
| Richard Milchior | Herald Avocats, France |
| Vijay Raghavan | Sandoz, Switzerland |
| Sandeep K. Rathod | USV Private Limited, India |
| Juichi Riku | Consultant, Japan |
| Paolo Romangnoli | Pharmaceutical Chemicals, Italy |
| Sol Ruiz | Spanish Medicines Agency (AEMPS), Spain |
| Enrique Seoane-Vasquez | Massachusetts College of Pharmacy and Health Sciences, USA |
| Abhishek Sharma | Jefferies, India |
| Steven Simoens | Catholic University of Leuven, Belgium |
| Lawrence Yu | University of Michigan, USA |
| Keith A. Zullow | Partner, Goodwin Procter LLP, USA |
Manuscript submission guidelines can be accessed on Sage Journals.